Related Experiment Video
Updated: Jul 8, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Infant botulism: 20 years' experience at a single institution
Linda Tseng-Ong1, Wendy G Mitchell
1Neurology Division, Childrens Hospital Los Angeles, California 90027, USA.
Journal of Child Neurology
|January 5, 2008
Summary
Botulism immune globulin treatment shortened infant hospital stays and reduced the need for some interventions. However, meticulous supportive care remains crucial for infant botulism recovery.
Area of Science:
- Pediatrics
- Infectious Diseases
- Toxicology
Background:
- Infant botulism is a serious condition requiring hospitalization and intensive care.
- The availability of botulism immune globulin (BIG) offered a potential new treatment modality.
Purpose of the Study:
- To evaluate the clinical presentation, course, and outcomes of infant botulism.
- To assess the impact of botulism immune globulin treatment on patient outcomes.
Main Methods:
- Retrospective review of infant botulism admissions from 1985-2005.
- Analysis of clinical data, including demographics, presenting features, interventions, and treatment with botulism immune globulin.
Main Results:
- Infants treated with botulism immune globulin had significantly shorter hospital stays (13.5 vs. 23 days).
- A trend towards reduced nasogastric feeding and shorter tracheal intubation duration was observed in treated infants.
- Despite advances, ventilator support and nasogastric feeding remained common interventions.
Conclusions:
- Botulism immune globulin treatment appears to improve outcomes in infant botulism, particularly length of stay.
- Meticulous supportive care, including respiratory and nutritional support, remains essential for recovery.
- Further research may explore optimal timing and use of botulism immune globulin.
Related Concept Videos
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:11Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...